tradingkey.logo
tradingkey.logo
Pesquisar

Caris Life Sciences Inc

CAI
Adicionar à lista de desejos
17.820USD
-0.500-2.73%
Fechamento 06/30, 16:00ETCotações atrasadas em 15 min
5.04BValor de mercado
PerdaP/L TTM

Mais detalhes de Caris Life Sciences Inc Empresa

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Informações de Caris Life Sciences Inc

Código da empresaCAI
Nome da EmpresaCaris Life Sciences Inc
Data de listagemJun 18, 2025
CEOHalbert (David Dean)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 18
Endereço750 W. John Carpenter Freeway
CidadeIRVING
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75039
Telefone18667718946
Sitehttps://www.carislifesciences.com/
Código da empresaCAI
Data de listagemJun 18, 2025
CEOHalbert (David Dean)

Executivos da empresa Caris Life Sciences Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
513.30K
+0.31%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
153.77K
-6.35%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
--
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
513.30K
+0.31%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
153.77K
-6.35%
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
2.49K
--
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Caris Life Sciences Inc?

Os cinco principais acionistas de Caris Life Sciences Inc são: Dr. George H. Poste, Ph.D.
KeyAI